Trials / Recruiting
RecruitingNCT05275972
Descemet Endothelial Thickness Comparison Trial II
Descemet Endothelial Thickness Comparison Trials (DETECT I & II)
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ripasudil | Topical Ripasudil 0.4% |
| DRUG | Placebo | Topical Placebo |
Timeline
- Start date
- 2023-01-23
- Primary completion
- 2027-11-30
- Completion
- 2028-11-30
- First posted
- 2022-03-11
- Last updated
- 2025-12-18
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05275972. Inclusion in this directory is not an endorsement.